| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
2 companies
Katabi Maha is a Director, 10% Owner at JBIO, with reported holdings spanning 2 companies. Recent filings cover 3 purchases and 6 sales. Those positions are worth an estimated $113.2M at current prices.
Our model assigns Katabi Maha a strong insider score of 71/100, based on 6 past trades. Over a 12-month horizon, 83.3% of those trades were profitable, with an average 12-month return of +22.2%.
Katabi Maha's largest disclosed position is in VERA as Director, worth about $113.2M. Net of sales, the recent Form 4 record there shows accumulation of 54,103 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2024 | VERA Vera Therapeutics, Inc. | Director | Sell | 834,459 | $40.86 | $34,099,582.58 | -23.0% | -15.3% | -34.6% | |
| Jan 30, 2024 | VERA Vera Therapeutics, Inc. | Director | Buy | 161,290 | $31.00 | $4,999,990.00 | +4.7% | +19.9% | +9.9% | |
| Jul 2, 2021 | JBIO Jade Biosciences, Inc. | Director, 10% Owner | Buy | 357,142 | $14.00 | $4,999,988.00 | +10.5% | +5.2% | -15.1% | |
| May 18, 2021 | VERA Vera Therapeutics, Inc. | Director, 10% Owner | Buy | 727,272 | $11.00 | $7,999,992.00 | +33.2% | +37.7% | +32.9% |